Table of Contents Author Guidelines Submit a Manuscript
Table of Contents Alerts

To receive news and publication updates for Mediators of Inflammation, enter your email address in the box below.

Mediators of Inflammation
Volume 2015, Article ID 235797, 10 pages
http://dx.doi.org/10.1155/2015/235797
Research Article

Macrophage Differentiation from Monocytes Is Influenced by the Lipid Oxidation Degree of Low Density Lipoprotein

Jin-Won Seo,1 Eun-Jeong Yang,1 Kyung-Hwa Yoo,2 and In-Hong Choi1

1Department of Microbiology, Institute for Immunology and Immunological Diseases, Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul 120-752, Republic of Korea
2Department of Physics, Yonsei University, Seoul 120-752, Republic of Korea

Received 3 March 2015; Revised 5 July 2015; Accepted 6 July 2015

Academic Editor: Vinod K. Mishra

Copyright © 2015 Jin-Won Seo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. X. H. Yu, Y. C. Fu, D. W. Zhang, K. Yin, and C. K. Tang, “Foam cells in atherosclerosis,” Clinica Chimica Acta, vol. 424, pp. 245–252, 2013. View at Google Scholar
  2. K. Z. Boudjeltia, J. Daher, P. van Antwerpen et al., “Exposure of endothelial cells to physiological levels of myeloperoxidase-modified LDL delays pericellular fibrinolysis,” PLoS ONE, vol. 7, no. 6, Article ID e38810, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Tsimikas and Y. I. Miller, “Oxidative modification of lipoproteins: mechanisms, role in inflammation and potential clinical applications in cardiovascular disease,” Current Pharmaceutical Design, vol. 17, no. 1, pp. 27–37, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Cominacini, A. F. Pasini, U. Garbin et al., “Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species,” The Journal of Biological Chemistry, vol. 275, no. 17, pp. 12633–12638, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Essler, M. Retzer, M. Bauer, K. J. Zangl, G. Tigyi, and W. Siess, “Stimulation of platelets and endothelial cells by mildly oxidized LDL proceeds through activation of lysophosphatidic acid receptors and the Rho/Rho-kinase pathway. Inhibition by lovastatin,” Annals of the New York Academy of Sciences, vol. 905, pp. 282–286, 2000. View at Google Scholar · View at Scopus
  6. G. K. Hansson, “Inflammatory mechanisms in atherosclerosis,” Journal of Thrombosis and Haemostasis, vol. 7, supplement 1, pp. 328–331, 2009. View at Google Scholar
  7. S. A. Isa, J. S. Ruffino, M. Ahluwalia, A. W. Thomas, K. Morris, and R. Webb, “M2 macrophages exhibit higher sensitivity to oxLDL-induced lipotoxicity than other monocyte/macrophage subtypes,” Lipids in Health and Disease, vol. 10, article 229, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. A. V. Sokolov, V. A. Kostevich, O. L. Runova et al., “Proatherogenic modification of LDL by surface-bound myeloperoxidase,” Chemistry and Physics of Lipids, vol. 180, pp. 72–80, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Z. Boudjeltia, I. Legssyer, P. Van Antwerpen et al., “Triggering of inflammatory response by myeloperoxidase-oxidized LDL,” Biochemistry and Cell Biology, vol. 84, no. 5, pp. 805–812, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Colin, G. Chinetti-Gbaguidi, and B. Staels, “Macrophage phenotypes in atherosclerosis,” Immunological Reviews, vol. 262, no. 1, pp. 153–166, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. F. De Paoli, B. Staels, and G. Chinetti-Gbaguidi, “Macrophage phenotypes and their modulation in atherosclerosis,” Circulation Journal, vol. 78, no. 8, pp. 1775–1781, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. G. K. Hansson and A. Hermansson, “The immune system in atherosclerosis,” Nature Immunology, vol. 12, no. 3, pp. 204–212, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Radhika and P. R. Sudhakaran, “Upregulation of macrophage-specific functions by oxidized LDL: lysosomal degradation-dependent and -independent pathways,” Molecular and Cellular Biochemistry, vol. 372, no. 1-2, pp. 181–190, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Lefevre, M. Beljean-Leymarie, F. Beyerle et al., “Evaluation of lipid peroxidation by measuring thiobarbituric acid reactive substances,” Annales de Biologie Clinique (Paris), vol. 56, no. 3, pp. 305–319, 1998. View at Google Scholar
  15. C.-Y. Han and Y. K. Pak, “Oxidation-dependent effects of oxidized LDL: proliferation or cell death,” Experimental and Molecular Medicine, vol. 31, no. 4, pp. 165–173, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. M. E. Zettler, M. A. Prociuk, J. A. Austria, H. Massaeli, G. Zhong, and G. N. Pierce, “OxLDL stimulates cell proliferation through a general induction of cell cycle proteins,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 284, no. 2, pp. H644–H653, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Inoue, H. Itoh, T. Tanaka et al., “Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothelial cells through activation of peroxisome proliferator-activated receptor-γ,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 21, no. 4, pp. 560–566, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Daigneault, J. A. Preston, H. M. Marriott, M. K. B. Whyte, and D. H. Dockrell, “The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages,” PLoS ONE, vol. 5, no. 1, Article ID e8668, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. L. E. Padgett, A. R. Burg, W. Lei, and H. M. Tse, “Loss of NADPH oxidase-derived superoxide skews macrophage phenotypes to delay type 1 diabetes,” Diabetes, vol. 64, no. 3, pp. 937–946, 2015. View at Publisher · View at Google Scholar
  20. B. Osterud and E. Bjorklid, “Role of monocytes in atherogenesis,” Physiological Reviews, vol. 83, no. 4, pp. 1069–1112, 2003. View at Publisher · View at Google Scholar
  21. J. Mauer, B. Chaurasia, J. Goldau et al., “Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin,” Nature Immunology, vol. 15, no. 5, pp. 423–430, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Duluc, Y. Delneste, F. Tan et al., “Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells,” Blood, vol. 110, no. 13, pp. 4319–4330, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Takada, T. Hisamatsu, N. Kamada et al., “Monocyte chemoattractant protein-1 contributes to gut homeostasis and intestinal inflammation by composition of IL-10-producing regulatory macrophage subset,” Journal of Immunology, vol. 184, no. 5, pp. 2671–2676, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. L. C. Becker, “Yin and yang of MCP-1,” Circulation Research, vol. 96, no. 8, pp. 812–814, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Morimoto, M. Hirose, M. Takahashi et al., “MCP-1 induces cardioprotection against ischaemia/reperfusion injury: role of reactive oxygen species,” Cardiovascular Research, vol. 78, no. 3, pp. 554–562, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. V. Lubrano and S. Balzan, “LOX-1 and ROS, inseparable factors in the process of endothelial damage,” Free Radical Research, vol. 48, no. 8, pp. 841–848, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Taye and A. A. K. El-Sheikh, “Lectin-like oxidized low-density lipoprotein receptor 1 pathways,” European Journal of Clinical Investigation, vol. 43, no. 7, pp. 740–745, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Oh, A. E. Riek, S. Weng et al., “Endoplasmic reticulum stress controls M2 macrophage differentiation and foam cell formation,” Journal of Biological Chemistry, vol. 287, no. 15, pp. 11629–11641, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Hong, Y.-P. Bai, H.-C. Gao et al., “Ox-LDL induces endothelial cell apoptosis via the LOX-1-dependent endoplasmic reticulum stress pathway,” Atherosclerosis, vol. 235, no. 2, pp. 310–317, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. F. Zhang, C. Wang, H. Wang et al., “Ox-LDL promotes migration and adhesion of bone marrow-derived mesenchymal stem cells via regulation of MCP-1 expression,” Mediators of Inflammation, vol. 2013, Article ID 691023, 11 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. E. Cassol, L. Cassetta, C. Rizzi, M. Alfano, and G. Poli, “M1 and M2a polarization of human monocyte-derived macrophages inhibits HIV-1 replication by distinct mechanisms,” The Journal of Immunology, vol. 182, no. 10, pp. 6237–6246, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. E. Zajac, B. Schweighofer, T. A. Kupriyanova et al., “Angiogenic capacity of M1- and M2-polarized macrophages is determined by the levels of TIMP-1 complexed with their secreted proMMP-9.,” Blood, vol. 122, no. 25, pp. 4054–4067, 2013. View at Publisher · View at Google Scholar · View at Scopus